• Xanthippi Mavropoulou, Elisavet Psoma, Angeliki Papachristodoulou, Nikoletta Pyrrou, Ekaterini Spanou, Maria Alexandratou, Maria Sidiropoulou, Anastasia Theocharidou, Vasileios Rafailidis, Theofilos Chrysanthidis, and Panos Prassopoulos.
• Department of Clinical Radiology, AHEPA University Hospital of Thessaloniki, Aristotle University of Thessaloniki, 54634 Thessaloniki, Greece.
• Medicina (Kaunas). 2023 Jul 19; 59 (7).

AbstractThe potentially fatal COVID-19 pandemic has been associated with a largespectrum of clinical presentations. Beyond the classical pulmonary manifestations, gastrointestinal tract-related symptoms suchas nausea, diarrhea, abdominal distention and pain have been observed in patients, as a consequence of the binding of SARS-CoV-19 to Angiotensin-converting Enzyme 2 (ACE2) receptors in the gastrointestinal (GI) tract. The early recognition ofspecific imaging features, including hepatobiliary involvement, pancreatic involvement, development of solid organ infarcts, ischemic bowel changes and vascular occlusion, plays a key role through the course of the disease. Also, suspicious symptoms, especially in critically ill patients with clinical and biochemical markers of hypovolemia, necessitate timely imaging for bleeding complications. The aim of this pictorial review is to illustrate the spectrum of the GIimaging findings in patients with COVID-19. Awareness of diagnostic imaging hallmarks is crucial to optimize the management of these patients.

15 keywords...

hide…